Sun Pharma Announces Launch Of Generic Exelon(R) In US
Links shared publicly online about this topic.
- 1,040total visits
Sun Pharma Announces Launch Of Generic Exelon(R) In US
Sun Pharma announced launch of generic Exelon®, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease Medication, Parkinson's Disease, Pharma, Exelon
Most Recently Shared on July 7, 2010 at 4:09 pm By:
Sun Pharma Announces Launch Of Generic Exelon(R) In US http://mnt.to/3FMX #regulatory
Also Shared By:
Sun Pharma introduces generic rivastigmine capsules in U.S. market
news-medical.net — “Sun Pharma announced launch of generic Exelon, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.” View full resource at news-medical.net
Most Recently Shared on July 2, 2010 at 6:23 am By:
Sun Pharma introduces generic rivastigmine capsules in U.S. market: Sun Pharma announced launch of generic Exelon,... http://bit.ly/8Xi8nH
Advertisement
MNT Parkinson's News
@mnt_parkinsons
Sun Pharma Announces Launch Of Generic Exelon(R) In US http://mnt.to/3FMX #parkinsons
1 year ago...